Pier Capital’s Biogen BIIB Stock Holding History

Pier Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-161	Closed	-$53K	–	116
2014 Q3	$53K	Sell	161 -7	-4%	-$2.31K	0.01%	126
2014 Q2	$53K	Buy	+168	New	+$50.6K	0.01%	131
2013 Q3	–	Sell	-257	Closed	-$55K	–	139
2013 Q2	$55K	Buy	+257	New	+$54.9K	0.01%	117

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Pier Capital's BIIB Position: Q4 2014 in Review

Pier Capital sold out of Biogen (BIIB) in Q4 2014, closing a stake of 161 shares — an estimated $53K sold.

Pier Capital first reported a position in BIIB in Q2 2013 and held it in 3 quarters. The position peaked at $55K in Q2 2013. 885 funds tracked by Wall St. Rank hold BIIB as of Q4 2014.

Pier Capital reported no remaining Biogen position as of Q4 2014 after selling out during the quarter.
Pier Capital sold 161 Biogen shares in Q4 2014, an estimated $53K.
Pier Capital first reported a position in Biogen in Q2 2013 and held it in 3 quarters.
Pier Capital's Biogen position peaked at $55K in Q2 2013.
885 funds tracked by Wall St. Rank held Biogen as of Q4 2014.

Based on Pier Capital's 13F filing for Q4 2014, filed 10 Feb 2015.